Skip to search formSkip to main contentSkip to account menu

Viracept

Known as: Agouron Brand of Nelfinavir Mesylate, Roche Brand of Nelfinavir Mesylate 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

NelfinavirNelfinavir Mesylate
Nelfinavir Oral Tablet [Viracept]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
2009
2009
The Viracept-EMS case: impact and outlook.
2009
2009
EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
2007
2007
Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
2004
2004
In Vitro Studies of the Effects of HAART Drugs and Excipients on Activity of Digestive Enzymes
AbstractPurpose. Side effects of diarrhea and steatorrhea diminish the therapeutic value of highly active antiretroviral therapy… 
2003
2003
A process in need is a process indeed: scalable enantioselective synthesis of chiral compounds for the pharmaceutical industry.
This report deals with enantioselective synthesis of viracept 1 (nelfinavir mesylate, AG 1343), a potent HIV protease inhibitor… 
2002
2002
A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Summary Forty (40) HIV positive patients with CD4 cell counts between 100 - 500 cellh/mm3 were recruited from 8 different centres… 
Highly Cited
2001
Highly Cited
2001
Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities
ABSTRACT Nelfinavir mesylate (Viracept, formally AG1343) is a potent and orally bioavailable human immunodeficiency virus (HIV… 
2001
2001
Synthesis of nucleoside analogs and new Tat protein inhibitors
Two studies, concerning the synthesis of original nucleoside analogs regarded as an application of heterochemistry on… 
1997
1997
Nelfinavir (Viracept) approved: fourth protease inhibitor available.
The Food and Drug Administration (FDA) approved nelfinavir (Viracept) for both adult and pediatric use for treatment of HIV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)